Sign Out
Pregnancy: For sugammadex no clinical data on exposed pregnancies are available.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/fetal development, parturition or postnatal development.
Caution should be exercised when administering sugammadex to pregnant women.
Lactation: It is unknown whether sugammadex is excreted in human breast milk. Animal studies have shown excretion of sugammadex in breast milk. Oral absorption of cyclodextrins in general is low and no effects on the suckling child are anticipated following a single dose to the breast-feeding woman.
Caution should be exercised when administering sugammadex to a breast-feeding woman.
